What is eScreen?
Founded in 1998 and headquartered in Kansas City, Missouri, eScreen, Inc. operates as a specialized provider of comprehensive drug testing services. The company distinguishes itself through a robust portfolio that includes urine, oral fluid, and hair-based testing protocols. Central to its technological infrastructure is the Quantisal Lab Oral Fluid Collection Device, which facilitates efficient and accurate diagnostic outcomes. By integrating advanced laboratory technology with streamlined collection processes, eScreen serves as a vital partner for organizations seeking to maintain rigorous safety and compliance standards across their workforce operations.
How much funding has eScreen raised?
eScreen has raised a total of $8M across 1 funding round:
Series B
$8M
Series B (2008): $8M with participation from The Carlyle Group
Key Investors in eScreen
The Carlyle Group
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America. The company manages numerous funds focused on four primary investment disciplines: buyouts, venture and growth capital, real estate, and leveraged finance.
What's next for eScreen?
With the support of major institutional backing, eScreen is well-positioned to scale its enterprise-level diagnostic capabilities. The strategic deployment of this capital will likely focus on enhancing the scalability of its collection device distribution and deepening its integration into corporate human resources and safety management systems. As the demand for reliable, rapid, and legally defensible drug testing continues to rise, eScreen's focus on technological innovation and operational efficiency will be paramount in maintaining its market leadership. Future growth initiatives are expected to prioritize the expansion of its digital testing platforms and the optimization of its nationwide laboratory network to meet the evolving needs of global employers.
See full eScreen company page
